Medical Metrics

Executive Summary

Medical Metrics, Inc. (MMI) is a Houston-based medical imaging core laboratory and contract research organization (CRO) that provides independent, centralized image analysis and endpoint adjudication for global clinical trials. Certified ISO 9001:2015 and operating since 2000, the company supports pharmaceutical, biotech, and medical device sponsors across multiple therapeutic areas. Its services span imaging strategy, protocol design, expert review, data interpretation, and regulatory submission support, positioning MMI as a critical partner in the development of new therapies and devices. The company's long track record and specialized expertise make it a trusted vendor in the increasingly complex and outsourced clinical trial landscape. MMI's competitive advantage lies in its decades of experience, robust quality management systems, and ability to manage imaging endpoints with high precision, reducing variability in trial results. As clinical trials become more global and imaging-based endpoints gain prominence (e.g., in oncology, neurology, and cardiovascular disease), demand for specialized core labs is expected to grow. However, MMI operates in a fragmented market with competition from larger CROs and emerging AI-driven analytics providers. The company's growth will depend on its ability to innovate (e.g., AI-assisted image analysis), expand therapeutic coverage, and secure high-value contracts. With a stable business model and recurring revenue from ongoing trials, MMI is well-positioned for steady, though not explosive, growth.

Upcoming Catalysts (preview)

• Q3 2026Expansion into Neurology Imaging Endpoints60% success
• Q4 2026Major Contract Win with Top-10 Pharma50% success
• Q2 2027FDA Clearance of AI-Powered Image Analysis Software40% success